CSIR's 2024 Healthcare Breakthroughs: Advancing Cancer Detection, Genetic Disorders, and Neurodegenerative Disease Research

Dr. Sandip Shah Appointed Chairman of NABL: A Visionary Leader in Indian Healthcare

Global and Indian Genetic Testing Market Trends in 2025

Mankind Pharma and Innovent Biologics Partner to Launch Groundbreaking PD-1 Immunotherapy in India

Duchenne Muscular Dystrophy: Diagnosis, Treatment, and Emerging Therapies

Ikena Oncology and Inmagene Biopharmaceuticals Announce Merger to Form ImageneBio

Fujirebio and Eisai Partner to Advance Diagnostics for Neurodegenerative Diseases

European Commission Approves Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H or dMMR mCRC

Deerfield Management to Acquire Singular Genomics for $20 Per Share in All-Cash Deal

EU Approval of Tagrisso Sets New Standard for EGFR-Mutated NSCLC Treatment

Aurobindo Pharma’s Subsidiary CuraTeQ Secures UK Approval for Bevacizumab Biosimilar

SCG Cell Therapy Partners with A*STAR BTI and NATi to Advance RNA-Based Therapeutics

Korea's National Bio Big Data Project: Advancing Precision Medicine with Macrogen and Illumina

GST Exemption Announced for Cancer Treatment Gene Therapy

AIIMS Develops Affordable CAR-T Cell Therapy for Multiple Myeloma

Home
/
update
/
details

MedGenome Expands Presence in East India Through Stake Acquisition in GenX Diagnostics

NextEdge Admin

10 Jul 2024

2 min 13 sec

MedGenome, a leader in genetic diagnostics in India, has acquired a stake in GenX Diagnostics, a prominent lab chain based in Odisha. This strategic partnership aims to bolster healthcare services in the region by merging MedGenome's extensive expertise and product range with GenX Diagnostics' established local presence and commitment to healthcare excellence.

Dr. Vedam Ramprasad, CEO of MedGenome, emphasized that this collaboration marks a significant expansion of their market footprint and test portfolio, which now spans over 1,300 tests. The acquisition is part of MedGenome's broader strategy to enhance accessibility to advanced diagnostic solutions in Tier 2 and Tier 3 cities across India. They aim to introduce new tests and further their goal of positioning Indian genomics on a global scale.

Dr. Biswajit Mohanty from GenX Diagnostics expressed optimism about the partnership, highlighting its potential to bring sophisticated healthcare solutions to Eastern India. The integration of MedGenome's omics solutions with GenX Diagnostics' local operations is expected to empower clinicians and consumers alike with state-of-the-art diagnostic tools.

Together, MedGenome and GenX Diagnostics envision a future where the people of Odisha benefit from superior healthcare through comprehensive and cutting-edge diagnostic capabilities. This collaboration not only strengthens their respective market positions but also promises to elevate standards of healthcare delivery in the region, catering to diverse medical needs and driving innovation in genetic diagnostics and research.